A. Angel

An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcome

E. Eden, E. Ben-Chetrit, P. Feigin, 2021, medRxiv.

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

K. Syrigos, E. Nicastri, L. Dagna, 2022, Cytokine.

Real-time IP-10 measurements as a new tool for inflammation regulation within a clinical decision support protocol for managing severe COVID-19 patients

E. Eden, R. Navon, A. Gelman, 2020, medRxiv.

Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19

E. Eden, R. Navon, A. Gelman, 2021, PloS one.

An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease

P. Singer, E. Eden, I. Kagan, 2023, Cytokine.